Local delivery of a cancer-favoring oncolytic vaccinia virus via poly (lactic-co-glycolic acid) nanofiber for theranostic purposes
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF PHARMACEUTICS552(1-2) · pp.437 · 2018
- 피인용
- Web of Science 34Scopus 39
- FWCI (Scopus)
- 1.7
- JCR IF
- JCR 2017 3.862
- ISSN
- 0378-5173
저자
- 바드리나트 나라아나사미제1저자Biomedical Science, School of Medicine, Pusan National University, Yangsan, South Korea
- 정영일Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
- 우현영Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- 방서영BIO-IT Foundry Technology Institute, Pusan National University, Busan, South Korea
- Kim, ChanAmogreentech Co. Ltd. Gyeonggi-do, South Korea
- 허정Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- 강대환Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Busan, South Korea
- 유소영교신저자Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
초록
Local delivery of viruses via nanomaterials has been demonstrated in the treatment of colon cancer. A cancer-favoring oncolytic vaccinia virus (CVV), which is an evolutionary cancer-favoring engineered vaccinia virus carrying the green fluorescent protein (GFP) gene, has antitumor efficacy in drug-resistant colon cancer and metastatic liver cells. Here, we present the antitumor efficacy of a CVV coated a poly lactic-co-glycolic acid (PLGA) nanofiber for local drug delivery in theranostic approaches. In vitro- and in vivo-based analyses using mouse colon carcinoma models confirmed the therapeutic efficacy of CVV-PLGA nanofibers through diagnostic localization of the tumors and reduced tumor burden as a result of enhanced apoptosis. We propose that the CVV-PLGA nanofiber may be used for theranostic purposes in cancer therapy.
키워드
Poly (lactic-co-glycolic acid) nanofibersCancer-favoring oncolytic vaccinia virusCancer therapyTheranosticsHEPATOCELLULAR-CARCINOMAIN-VITROCONTROLLED-RELEASECOLORECTAL-CANCERLIVER-CANCERPOXVIRUSJX-594PLGATHERAPYNANOPARTICLES
식별자
- Scopus EID
- 2-s2.0-85054655559
- WoS UID
- 000447985800048



로그인
연구물 목록으로